- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | EXTRAWELL PHAR (00858): PROFIT ALERT | - | HKEx | ||
| 14.11. | EXTRAWELL PHAR (00858): DATE OF BOARD MEETING | 1 | HKEx | ||
| 15.10. | EXTRAWELL PHAR (00858): COMPLETION OF MAJOR TRANSACTION IN RELATION TO THE EXTENSION OF LOAN AGREEMENT AND PROVISION OF FINANCIAL ASSISTANCE | - | HKEx | ||
| 15.10. | EXTRAWELL PHAR (00858): POLL RESULTS OF THE SPECIAL GENERAL MEETING HELD ON 15 OCTOBER 2024 | 1 | HKEx | ||
| 26.09. | EXTRAWELL PHAR (00858): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF CIRCULAR CONTAINING NOTICE OF SPECIAL ... | - | HKEx | ||
| 26.09. | EXTRAWELL PHAR (00858): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF CIRCULAR CONTAINING NOTICE OF SPECIAL ... | - | HKEx | ||
| EXTRAWELL PHARMACEUTICAL Aktie jetzt für 0€ handeln | |||||
| 26.09. | EXTRAWELL PHAR (00858): NOTICE OF SPECIAL GENERAL MEETING | 1 | HKEx | ||
| 26.09. | EXTRAWELL PHAR (00858): FORM OF PROXY FOR SPECIAL GENERAL MEETING TO BE HELD ON TUESDAY, 15 OCTOBER 2024 AT 11:00 A.M. | - | HKEx | ||
| 26.09. | EXTRAWELL PHAR (00858): MAJOR TRANSACTION IN RELATION TO THE EXTENSION OF LOAN AGREEMENT AND PROVISION OF FINANCIAL ASSISTANCE AND NOTICE OF SPECIAL GENERAL ... | - | HKEx | ||
| 13.09. | EXTRAWELL PHAR (00858): DELAY IN DESPATCH OF CIRCULAR IN RELATION TO THE MAJOR TRANSACTION EXTENSION OF LOAN AGREEMENT AND PROVISION OF FINANCIAL ASSISTANCE | - | HKEx | ||
| 23.08. | EXTRAWELL PHAR (00858): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 23 AUGUST 2024 | 1 | HKEx | ||
| 12.08. | EXTRAWELL PHAR (00858): RETIREMENT OF AUDITOR AND WITHDRAWAL OF RESOLUTION AT THE ANNUAL GENERAL MEETING TO BE HELD ON 23 AUGUST 2024 | 1 | HKEx | ||
| 30.07. | EXTRAWELL PHAR (00858): MAJOR TRANSACTION EXTENSION OF LOAN AGREEMENT AND PROVISION OF FINANCIAL ASSISTANCE | - | HKEx | ||
| 26.07. | EXTRAWELL PHAR (00858): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF ANNUAL REPORT 2024, CIRCULAR CONTAINING ... | 1 | HKEx | ||
| 26.07. | EXTRAWELL PHAR (00858): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF ANNUAL REPORT 2024, CIRCULAR CONTAINING ... | 2 | HKEx | ||
| 26.07. | EXTRAWELL PHAR (00858): NOTICE OF ANNUAL GENERAL MEETING | - | HKEx | ||
| 26.07. | EXTRAWELL PHAR (00858): FORM OF PROXY FOR USE BY SHAREHOLDERS AT THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, 23 AUGUST 2024 AT 11:00 A.M. | - | HKEx | ||
| 26.07. | EXTRAWELL PHAR (00858): PROPOSALS FOR GENERAL MANDATES TO ISSUE NEW SHARES AND BUY BACK SHARES, RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL ... | - | HKEx | ||
| 26.07. | EXTRAWELL PHAR (00858): ANNUAL REPORT 2024 | - | HKEx | ||
| 28.06. | EXTRAWELL PHAR (00858): ANNUAL RESULTS FOR THE YEAR ENDED 31 MARCH 2024 | - | HKEx |
Seite:
1 2 Weiter >>
24 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| IONIS PHARMACEUTICALS | 31,690 | 0,00 % | Ionis Pharmaceuticals (NASDAQ:IONS) Hits New 12-Month Low on Insider Selling | ||
| CSPC PHARMA | 0,620 | -2,18 % | M Stanley Cuts CSPC PHARMA TP to $6.6 w/ Lower EPS Forecasts | ||
| ACADIA PHARMACEUTICALS | 15,300 | -0,94 % | Acadia Pharmaceuticals Inc - On Nov 18, Co Involuntarily Terminates COO Brendan Teehan | ||
| SELLAS LIFE SCIENCES | 1,132 | -3,41 % | SELLAS Life Sciences Group, Inc.: SELLAS Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Update | - Pre-specified Events to Trigger Interim Analysis of Phase 3 REGAL Study in Patients with Acute Myeloid Leukemia (AML) Remains on Track for Q4 2024 - - Data from the Phase 2a Trial of SLS009 in Relapsed/Refractory... ► Artikel lesen | |
| MADRIGAL PHARMACEUTICALS | 297,50 | -1,20 % | Novo semaglutide data in MASH could negatively impact Madrigal's Rezdiffra | ||
| CATALYST PHARMACEUTICALS | 20,090 | +0,10 % | Vorstandsvorsitzender von Catalyst Pharmaceuticals verkauft Aktien im Wert von 3,1 Millionen US-Dollar | ||
| OPUS GENETICS | 0,949 | +2,48 % | Foundation Fighting Blindness: The RD Fund Announces Ocuphire Pharma's Acquisition of Opus Genetics | The resulting company will operate under the name Opus Genetics and the Nasdaq ticker symbol (IRD)
RALEIGH, N.C., Oct. 25, 2024 /PRNewswire/ -- The RD Fund (Retinal... ► Artikel lesen | |
| ENZON PHARMACEUTICALS | 0,058 | 0,00 % | ENZON PHARMACEUTICALS, INC. - 10-Q, Quarterly Report | ||
| ELITE PHARMACEUTICALS | - | - | Elite Pharmaceuticals, Inc.: Elite Pharmaceuticals Receives FDA Approval for Generic Vyvanse | Northvale, New Jersey--(Newsfile Corp. - November 18, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company engaged in the development, manufacture... ► Artikel lesen | |
| VIRACTA THERAPEUTICS | 0,140 | -2,78 % | VIRX stock touches 52-week low at $0.15 amid market challenges | ||
| SAVARA | 2,800 | -6,04 % | Savara-Direktor Joseph McCracken erwirbt Stammaktien im Wert von 59.071 US-Dollar | ||
| GALECTIN THERAPEUTICS | 2,600 | -2,99 % | Galectin Therapeutics Inc.: Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2024 and Provides Business Update | NAVIGATE trial on track for top-line results in December 2024 NORCROSS, Ga., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that... ► Artikel lesen | |
| BIODEXA PHARMACEUTICALS | 4,420 | +19,78 % | Biodexa Pharmaceuticals PLC: Gaining Momentum, Biodexa is Advancing Two Recent Acquisitions Through the Clinic | CARDIFF, UK / ACCESSWIRE / November 21, 2024 / Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), an acquisition-focused clinical-stage biopharmaceutical company focused on developing treatments for unmet medical... ► Artikel lesen | |
| SCICLONE PHARMACEUTICALS | - | - | SCICLONE PHARMA (06600): (1) PROPOSAL FOR THE PRIVATISATION OF SCICLONE PHARMACEUTICALS (HOLDINGS) LIMITED BY SILVER PEGASUS INVESTMENT LIMITED BY WAY ... | ||
| NOVABAY PHARMACEUTICALS | 0,080 | 0,00 % | NovaBay calls for affirmative vote on asset sale and dissolution |
EXTRAWELL PHARMACEUTICAL HOLDINGS LTD gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EXTRAWELL PHARMACEUTICAL HOLDINGS LTD finden Sie auf Wallstreet Online.
